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Abstract 38 
Here we show that the cellular DNA replication protein and ATR substrate, SMARCAL1, is 39 
recruited to viral replication centres early during adenovirus infection and is then targeted in 40 
an E1B-55K/E4orf6 and Cullin Ring Ligase-dependent manner for proteasomal degradation. 41 
In this regard we have determined that SMARCAL1 is phosphorylated at S123, S129 and 42 
S173 early during infection, in an ATR- and CDK- dependent manner, and that 43 
pharmacological inhibition of ATR and CDK activities attenuates SMARCAL1 degradation. 44 
SMARCAL1 recruitment to viral replication centres was shown to be largely dependent upon 45 
SMARCAL1 association with the RPA complex, whilst Ad-induced SMARCAL1 46 
phosphorylation also contributed towards SMARCAL1 recruitment to viral replication 47 
centres, albeit to a limited extent. SMARCAL1 was found associated with E1B-55K in 48 
adenovirus E1-transformed cells. Consistent with its ability to target SMARCAL1 we 49 
determined that E1B-55K modulates cellular DNA replication. As such, E1B-55K expression 50 
initially enhances cellular DNA replication fork-speed but ultimately leads to increased 51 
replication fork stalling and the attenuation of cellular DNA replication. We propose 52 
therefore, that adenovirus targets SMARCAL1 for degradation during infection to inhibit 53 
cellular DNA replication and promote viral replication. 54 
 55 
 56 
 57 
 58 
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Importance 60 
Viruses have evolved to inhibit cellular DNA damage response pathways that possess anti-61 
viral activities and utilize DNA damage response pathways that possess pro-viral activities. 62 
Adenovirus has evolved, primarily, to inhibit DNA damage response pathways by engaging 63 
with the ubiquitin-proteasome system and promoting the degradation of key cellular proteins. 64 
Adenovirus regulates, differentially, ATR DNA damage response signalling pathways during 65 
infection. The cellular, adenovirus E1B-55K binding protein, E1B-AP5, participates in ATR 66 
signalling pathways activated during infection, whilst adenovirus 12 E4orf6 negates Chk1 67 
activation by promoting the proteasome-dependent degradation of ATR activator, TOPBP1. 68 
The studies detailed herein indicate that adenovirus utilises ATR kinase and CDKs during 69 
infection to promote the degradation of SMARCAL1 to attenuate normal cellular DNA 70 
replication. These studies further our understanding of the relationship between adenovirus 71 
and DNA damage and cell cycle signalling pathways during infection and establish new roles 72 
for E1B-55K in the modulation of cellular DNA replication. 73 
 74 
 75 
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Introduction 81 
Cellular DNA damage response (DDR) signalling pathways coordinated by the 82 
phosphoinositide 3-kinase (PI3K)-like kinase proteins Ataxia Telangiectasia Mutated (ATM), 83 
ATM-Rad3-related gene (ATR) and DNA-dependent protein kinase (DNA-PK) are often 84 
targeted by viruses during infection in order to facilitate viral replication (1, 2). As such, 85 
viruses often exploit the ubiquitin-proteasome system to inhibit DDR pathway components 86 
that possess anti-viral activities, and utilize DDR pathway components that possess pro-viral 87 
activities (1, 3). In this regard adenovirus (Ad) types from all groups have evolved, almost 88 
exclusively, to inhibit DDR pathways during infection. Early work determined that Ad5 E1B-89 
55K and E4orf6 assemble an Ad ubiquitin (Ub) ligase complex consisting of Cullin Ring 90 
Ligase 5 (CRL5), Elongin B, Elongin C and Rbx1 that was capable of promoting the specific 91 
degradation of the tumour suppressor gene product, p53 during infection (4, 5). In this regard 92 
BC box motifs within E4orf6 served to recruit CRL5 through association with Elongins B 93 
and C, whereas E1B-55K served to recruit p53 to the Ad Ub ligase through interaction with 94 
E4orf6 (6). Later studies indicated that group A viruses, such as Ad12, utilized CRL2 to 95 
promote the degradation of p53 during infection (7, 8).  96 
The Ad Ub ligase was subsequently shown to inhibit the ATM-coordinated response to viral 97 
infection by promoting the degradation of MRE11 and BLM to ensure that viral genome 98 
processing, resection, recombination and concatenation are all negated (9, 10). Adenovirus 99 
was also shown to inhibit non-homologous end-joining pathways coordinated by DNA-PK by 100 
targeting DNA ligase IV for Ad Ub ligase-mediated degradation that also served to prevent 101 
viral genome concatenation (11). The Ad Ub ligase has also been shown to promote the 102 
degradation of cellular proteins not involved in DDR signalling but do, nevertheless, possess 103 
anti-viral activities. As such cellular proteins involved in cell signalling, cell adhesion and 104 
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cell-contacts such as integrin 3, ALCAM, EPHA2 and PTPRF are all targeted for 105 
degradation during infection (12, 13). E1B-55K can also, in isolation, promote the 106 
proteasomal-mediated degradation of Daxx, a component of PML nuclear bodies and 107 
transcriptional regulator that has antiviral activities (14), whilst Ad E4orf3 which possesses 108 
inherent SUMO ligase activity can target cellular proteins such as TIF1 and TFII-I for 109 
SUMO-targeted ubiquitin ligase (STUbL) -mediated degradation during infection (15-17). 110 
The ATR kinase serves specifically to regulate pathways that control DNA replication in 111 
response to replication stress (18). ATR is an essential gene; hypomorphic mutations cause 112 
Seckel syndrome that is a pleiotropic disease characterized primarily by growth retardation 113 
and microcephaly (18). ATR signalling pathways are targeted, specifically, during Ad 114 
infection. It has long been known that the single-stranded (ss)DNA-binding protein complex, 115 
RPA, which participates in ATR signalling pathways through its association with ssDNA 116 
during cellular DNA replication and following resection at double-stranded (ds)DNA breaks 117 
(DSBs), is recruited to viral replication centres (VRCs) during Ad infection and presumably 118 
associates with viral ssDNA replication intermediates during genome replication (19, 20). As 119 
such RPA has often served as a surrogate marker for VRCs. More recently, a number of ATR 120 
signalling components required for ATR activation such as, ATR-interacting protein 121 
(ATRIP), and components of the RAD9-HUS1-RAD1 (9-1-1) clamp complex and Rad17, 122 
have all been shown to be recruited to VRCs following both Ad5 and Ad12 infection (19, 123 
20). It has also been suggested that Ad5, but not Ad12, inhibits the ATR-dependent activation 124 
of Chk1 by promoting the E4orf3-dependent immobilisation of the MRE11-RAD50-NBS1 125 
complex in nuclear tracks, whilst Ad12 E4orf6 alone associates with CRL2-Rbx1 to promote 126 
the degradation of the ATR activator, TOPBP1, and ensures that Chk1 is not activated during 127 
Ad12 infection (7, 20). It has been determined that the ATR pathway is differentially 128 
regulated during Ad infection. ATR kinase has been shown to be activated during both Ad5 129 
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and Ad12 infection and that the cellular Ad E1B-55K associated protein, E1B-AP5 130 
(hnRNPUL1), is required for ATR activation in these circumstances (20). Indeed, E1B-AP5 131 
was shown to be required for the ATR-dependent phosphorylation of RPA32 during infection 132 
and also contributed towards the Ad-induced phosphorylation of Smc1 and H2AX. It is not 133 
however, apparent why ATR kinase activity is not fully inactivated during Ad infection, and 134 
suggests that the virus might promote the selective ATR-dependent phosphorylation of 135 
specific substrates during infection to inhibit cellular replication and facilitate viral 136 
replication (20).  137 
SMARCAL1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 138 
subfamily A-like protein 1) is a DNA-dependent ATPase and ATP-dependent annealing 139 
helicase that has the capacity to interact with both dsDNA and ssDNA through DNA-140 
binding-domains (DBDs) within its primary structure and its interaction with the RPA 141 
complex, respectively (21-25). Bi-allelic inactivation of SMARCAL1 causes Schimke 142 
immuno-osseous dysplasia (SIOD) which is characterized by renal failure, immune 143 
deficiencies, bone growth retardation, and predisposition to different types of cancer (26). 144 
SMARCAL1 has the capacity to remodel replication forks and serves to prevent replication 145 
fork collapse and promote replication restart (21-25). As such SMARCAL1 is recruited to 146 
stalled forks through its interaction with RPA to promote fork regression and the restoration 147 
of fork structure. SMARCAL1 function is regulated by the ATR kinase; in response to 148 
replication stress ATR phosphorylates SMARCAL1 on S652 and limits its fork regression 149 
and fork processing activities (27). Indeed, when ATR is inhibited pharmacologically such 150 
that SMARCAL1 activity is not tightly regulated, uncoordinated SMARCAL1 activity 151 
promotes fork collapse (28). SMARCAL1 also participates directly in response to different 152 
types of DNA damage and is recruited in an RPA-dependent manner to DSBs that have been 153 
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processed to generate ssDNA, and serves to both stabilize replication forks, and restore fork 154 
integrity (21-25).   155 
As our understanding of the relationship between ATR signalling pathways and adenovirus is 156 
incomplete this study sought to further our knowledge in this area. As such we determined 157 
that the ATR substrate, SMARCAL1 is phosphorylated in ATR and CDK-dependent manner 158 
and then targeted for degradation during adenovirus infection to presumably to disable its 159 
cellular activities during infection. Consistent with this notion, E1B-55K, which associates 160 
specifically with SMARCAL1, was shown to dysregulate cellular DNA replication fork 161 
speed and promote replication fork stalling. We propose therefore that adenovirus inhibits 162 
SMARCAL1 activity to effectively inactivate cellular DNA replication during infection. 163 
 164 
Materials and Methods 165 
Cells. A549 human lung carcinoma cells, TERT-immortalized RPE-1 (retinal pigment 166 
epithelial) cells, FlpIn T-REX U2OS cells and GP2-293 cells were grown in HEPES-167 
modified Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich) supplemented with 168 
8% (v/v) foetal calf serum (FCS; Sigma-Aldrich) and 2 mM L-glutamine (Sigma-Aldrich). 169 
Ad5 and Ad12 E1B-55K FlpIn T-Rex U2OS cells were maintained in HEPES-modified 170 
DMEM media in the presence of 200μg/ml Hygromycin (Life Technologies), whilst clonal 171 
RPE-1 cells that express wild-type (wt) GFP-SMARCAL1 or GFP-SMARCAL1 mutants 172 
were also maintained in HEPES-modified DMEM media in the presence of 500μg/ml G418 173 
(Gibco). All cells were maintained at 37 ºC in a humidified 5% CO2 atmosphere (Nuaire 174 
Autoflow). 175 
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Viruses. wt Ad5 and wt Ad12 Huie viruses were from the ATCC. Ad5 dl1520, Ad5 pm4150, 176 
Ad5 pm4154 Ad5 pm4155 and Ad12 dl620 viruses have all been described previously (15). 177 
Ad5 and Ad12 viruses were propagated on permissive human embryonic kidney (HEK) 293 178 
cells and human embryonic retinoblastoma (HER) 3 cells, respectively, and titres determined 179 
by plaque assay on HER911, and HER3 cells, respectively. Viruses were diluted in DMEM 180 
without FCS and cells were typically infected at a multiplicity of infection (MOI) of 10. 181 
Infected cells were incubated at 37 °C with agitation every 10 minutes. After 2 hours 182 
infection, virus-containing medium was removed and replaced with fresh culture medium 183 
supplemented with 8% (v/v) FCS. 184 
Plasmids. wt SMARCAL1 and N-SMARCAL1 (lacking the N-terminal RPA-interaction 185 
domain; RPA)  constructs cloned into the retroviral vector pLEGFP-C1 (Clontech) were 186 
provided by Dr David Cortez. pLEGFP-C1 S123A, S129A and S173A SMARCAL1 187 
phospho-mutants were generated using the QuikChange II XL site-directed mutagenesis kit 188 
(Agilent) and validated by Sanger sequencing. Using wt Ad5 E1B-55K and Ad12 E1B-55K 189 
cDNA templates both Ad5 and Ad12 E1B-55K were amplified by PCR, digested with 190 
BamHI and XhoI, and sub-cloned into the pcDNA5/FRT/TO plasmid for the generation of 191 
TET-inducible cell lines. Ad5 E1B-55K was amplified using the primers: Ad5 E1B55K 192 
BamHI Forward: AGGTTGGATCCATGGAGCGAAGAAACCCATCTGAG and Ad5 193 
E1B55K XhoI Reverse: AGGTTCTCGAGTCAATCTGTATCTTCATCGCTAGA.  Ad12 194 
E1B-55K was amplified using the primers: Ad12 E1B55K BamHI Forward: 195 
TTGCAGGATCCATGGAGCGAGAAATCCCACCTGAG and Ad12 E1B55K XhoI 196 
Reverse: TTGCACTCGAGTCAGTTGTCGTCTTCATCACTTGA. Clones were validated 197 
by Sanger sequencing using the primers pcDNA5 Forward: 198 
CGCAAATGGGCGGTAGGCGTG; pcDNA5 Reverse: TAGAAGGCACAGTCGAGG; 199 
Ad5 E1B-55K seq1: GGCTACAGAGGAGGCTAGGAATCTA; Ad5 E1B-55K seq2: 200 
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CCTGGCCAATACCAACCTTATCCT; Ad5 E1B-55K seq3: 201 
TGCTGACCTGCTCGGACGGCAACT; Ad12 E1B-55K seq1: 202 
AACTGTATATTGGCAGGAGTTGCAG; Ad12 E1B-55K seq2: 203 
AATACCTGTCTTGTCTTGCATGGT; Ad12 E1B-55K seq3: 204 
ATAACATGTTTATGCGCTGTACCAT. 205 
Generation of clonal cell lines. FlpIn T-REX U2OS cells were grown to 90% confluence 206 
prior to transfection. The Ad5 E1B-55K and Ad12 E1B-55K pcDNA5/FRT/TO plasmids 207 
were mixed with the recombination plasmid, pOG44, in a 1:9 ratio in Opti-MEM (Life 208 
Technologies), and transfected according to the manufacturer’s instructions into FlpIn T-209 
REX U2OS cells with the use of Lipofectamine 2000 (Life Technologies). Cells were then 210 
incubated in a CO2-humidified incubator at 37°C for 6 hours. Following transfection cells 211 
were incubated in fresh HEPES-modified DMEM supplemented with 8% (v/v) FCS and 212 
2mM glutamine. 24 h post-transfection cells from one plate were passaged onto four plates, 213 
and 48h post-transfection incubated with growth medium containing 200μg/ml Hygromycin 214 
(Life Technologies) for clonal selection. Cells were then fed every three days; individual 215 
colonies were ultimately selected, expanded and assessed for Ad E1B-55K expression 216 
following incubation with 0.1μg/ml doxycycline for 24h. To generate GFP-SMARCAL1 cell-217 
lines, pLEGFP-C1 SMARCAL1 constructs were transfected in a 1:1 ratio with the pVSV 218 
envelope plasmid in the retrovirus packaging cell line, GP2-293 cells (Clontech) using 219 
Lipofectamine 2000. 72 h post-transfection, the virus-containing supernatants were collected 220 
and filtered through a 0.45 M filter (Sartorius). Retroviral transduction of RPE-1 cells, at 221 
20% density, was then performed. 72 h post-transduction clonal cells were selected using 222 
G418 (500 g/ml). Individual colonies were ultimately expanded and assessed for GFP-223 
SMARCAL1 expression. 224 
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Antibodies and inhibitors. The anti-Ad5 E1B-55K monoclonal antibody (mAb), 2A6, anti-225 
Ad12 E1B-55K mAb, XPH9 and the anti-p53 mAb, DO-1 were all obtained as supernatant 226 
fluid from cultures of the appropriate hybridoma cell lines. The anti-SMARCAL1 (A-2) mAb 227 
was from Santa Cruz (sc-376377). Horseradish peroxidase (HRP)-conjugated secondary anti-228 
mouse and anti-rabbit antibodies used for Western blotting were from Agilent. Secondary 229 
anti-mouse and anti-rabbit Alexa 488/594 antibodies used for immunofluorescence were from 230 
Thermo Fisher. The ATR inhibitor, AZD6738, and the CRL inhibitor, MLN4924, were 231 
purchased from Cayman chemicals, whilst the CDK inhibitor, RO-3306 was purchased from 232 
Merck Millipore. 233 
Immunoprecipitation. Cells were harvested by washing twice in ice-cold phosphate-234 
buffered saline and solubilized in immunoprecipitation (IP) buffer containing 20 mM Tris–235 
HCl (pH 8.0), 150 mM NaCl, 1
 
mM ethylenediaminetetraacetic acid (EDTA), 1% (v/v) 236 
Nonidet P-40, 25 mM NaF and 25 mM β-glycerophosphate. Cell lysates were then 237 
homogenized twice with 10 strokes while being kept on ice and centrifuged at 40000 rpm for 238 
30 minutes at 4 °C. Immunoprecipitating antibodies were added to clarified supernatants at 4 239 
°C overnight with rotation. After this time Protein G-Sepharose beads (Sigma-Aldrich) were 240 
added to all samples to capture and isolate immune complexes for 2 hours at 4 °C with 241 
rotation. The beads were then washed five times by centrifugation at 3000 rpm in ice-cold IP 242 
buffer, eluted in 30 μl of SDS-containing sample buffer and ran on SDS-PAGE gels for 243 
Western blotting.  244 
SDS-PAGE and Western blot analysis. Whole-cell protein lysates were prepared in 9M 245 
urea, 150 mM -mercaptoethanol, 50 mM Tris-HCl (pH 7.4). Lysates were clarified by 246 
sonication and centrifugation, and protein concentrations determined by Bradford assay (Bio-247 
Rad). Proteins were separated by SDS–PAGE in the presence of 100 mM Tris, 100 mM 248 
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Bicine and 0.1% (w/v) SDS. Following SDS-PAGE, proteins where electrophoretically 249 
transferred onto nitrocellulose membranes (PALL) in transfer buffer (50 mM Tris, 190 mM 250 
glycine, 20% (v/v) methanol). Membranes were then blocked in 5% (w/v) dried milk powder 251 
in TBST (Tris-buffered saline containing 0.1% (v/v) Tween-80) for 1 h at room temperature 252 
with agitation. Membranes were incubated overnight with antibodies at the appropriate 253 
dilution in TBST containing 5% (v/v) milk at 4 °C with agitation. The following day, 254 
membranes were washed four times in TBST and incubated with the appropriate HRP-255 
conjugated secondary antibody made up in TBST containing 5% (v/v) milk at room 256 
temperature for 2 hours with agitation. Finally, membranes were washed four times in TBST 257 
and antigens were detected using enhanced chemiluminescence (ECL) reagents (Millipore) 258 
and autoradiography film (SLS). 259 
Microscopy. GFP-SMARCAL1 cells were visualised using an EVOS Fluorescent digital 260 
inverted microscope. Cells for confocal microscopy were seeded on glass 12-well multi-spot 261 
microscope slides (Hendley-Essex). Following mock or Ad infection slides were fixed in 4% 262 
(w/v) paraformaldehyde in PBS then permeabilized in ice-cold acetone. Slides were then air-263 
dried, and blocked in HINGS buffer (20% (v/v) Heat-Inactivated Normal Goat Serum, 0.2% 264 
(w/v) BSA in PBS), prior to incubation with the appropriate primary, and Alexa Fluor® 265 
secondary antibodies (Life Technologies) in HINGS buffer. Slides were then mounted in 266 
Vectashield (Vector Laboratories) containing 4’,6-diamidino-2-phenylindole (DAPI) and 267 
visualized using an LSM 510 META confocal laser scanning microscope (Carl Zeiss). 268 
Mass Spectrometry. Anti-SMARCAL1 immunoprecipitates were isolated on Protein G 269 
Sepharose beads and separated upon pre-cast Novex NuPage
TM
 4-12% Bis-Tris Gels (Life 270 
Technologies). Protein bands were stained with colloidal Coomassie Brilliant Blue (Fisher). 271 
After washing gels in distilled water protein bands were excised and washed twice, by 272 
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agitation, with a solution containing 50 mM ammonium bicarbonate and 50% (v/v) 273 
acetonitrile for 45 min at 37°C.  The excised proteins were then reduced by incubation for 1 h 274 
at 56°C in a solution containing 50 mM dithiothreitol and 50 mM ammonium bicarbonate in 275 
10% (v/v) acetonitrile. Proteins were then incubated in an alkylating solution (200 mM 276 
iodoacetamide, 50 mM ammonium bicarbonate, and 10% (v/v) acetonitrile) for 30 min at 277 
room temperature in the dark. The protein bands were then washed three times for 15 min 278 
each at room temperature in 10% (v/v) acetonitrile /40 mM ammonium bicarbonate on a 279 
shaker, and then dried in a DNA–mini-vacuum centrifuge for 3-4 h. The dried samples were 280 
then resuspended and digested by rehydration in sequence-grade modified trypsin (Promega). 281 
An equal volume of 10% (v/v) acetonitrile/40mM ammonium bicarbonate was then added to 282 
the protein bands and left to incubate with agitation overnight at 37°C. The resultant peptides 283 
were then analyzed using a Q Exactive™ HF Hybrid Quadrupole-Orbitrap™ Mass 284 
Spectrometer (ThermoFisher Scientific). 285 
DNA fibre analysis. Cells were labelled with 25 μM CldU (Sigma-Aldrich) and 250 μM IdU 286 
(Sigma-Aldrich) for 20 min each and DNA fibre spreads prepared in 200 mM Tris-HCl pH 287 
7.4, 50 mM EDTA, 0.5% (w/v) SDS and fixed with a 3:1 mixture of methanol/acetic acid. 288 
DNA fibre spreads were then denatured with 2.5 M HCl for 80 mins then incubated with 289 
blocking buffer (PBS + 1% (w/v) BSA + 0.1% (v/v) Tween20) for 1 h prior to incubation 290 
with rat anti-BrdU (BU1/75, Abcam ab6326, 1:250) and mouse anti-BrdU (B44, Becton 291 
Dickinson 347580, 1:500) in blocking buffer for 1 h. Fibres were then fixed with 4% (w/v) 292 
paraformaldehyde and incubated further with anti-rat AlexaFluor 555 and anti-mouse 293 
AlexaFluor 488 for 1.5 h prior to mounting and analysis on a Nikon E600 microscope with a 294 
Nikon Plan Apo 60x (1.3 NA) oil lens, a Hamamatsu digital camera (C4742-95) and the 295 
Volocity acquisition software (Perkin Elmer). Images were analyzed using ImageJ. 296 
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 297 
Results 298 
SMARCAL1 localizes to Ad replication centres during the early stages of infection. As 299 
we and others have shown that the RPA complex and other components of ATR signalling 300 
pathways are recruited to VRCs during infection we decided initially to determine whether 301 
SMARCAL1, a known ATR substrate and RPA-binding protein, was also recruited to VRCs 302 
following infection of human A549 cells with either wt Ad5 or wt Ad12. Confocal 303 
microscopy revealed that like RPA complex component, RPA2, SMARCAL1 was distributed 304 
predominantly, throughout the nucleus in mock-infected, interphase A549 cells, although 305 
there did also appear to be a proportion of cytoplasmic SMARCAL1 (panels i-iii, Figure 1). 306 
Following infection with either wt Ad5, or wt Ad12, and consistent with previous studies 307 
RPA2 re-localized to VRCs (panels iv-vi, Ad5; panels vii-ix, Ad12; Figure 1). Importantly, 308 
SMARCAL1 was also recruited to VRCs, and co-localized with RPA2, following either wt 309 
Ad5, or wt Ad12 infection (panels iv-vi, Ad5; panels vii-ix, Ad12; Figure 1). Interestingly, 310 
the levels of SMARCAL1 in the Ad12-infected cells appeared to be reduced relative to 311 
mock-infected cells (cf panel ii (mock) with panel viii (Ad12), Figure 1). Taken together 312 
these data indicate that SMARCAL1 is recruited to VRCs during Ad infection. 313 
SMARCAL1 protein levels are reduced following Ad5 and Ad12 infection. Given that the 314 
immunofluorescence studies suggested that SMARCAL1 levels were reduced following 315 
Ad12 infection (Figure 1) we next sought to determine whether absolute SMARCAL1 protein 316 
levels are affected by viral infection. To do this we infected A549 cells with either wt Ad5 or 317 
wt Ad12 and analysed SMARCAL1 protein levels at various stages post-infection. Western 318 
Blot (WB) analyses revealed that akin to p53, SMARCAL1 protein levels were reduced 319 
substantially following wt Ad5 infection (Figure 2A). WB analyses revealed that 320 
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SMARCAL1 protein levels were similarly reduced following wt Ad12 infection (Figure 2B). 321 
Interestingly, WB analyses revealed that SMARCAL1 appeared to undergo post-translational 322 
modification at early time-points post-infection, as judged by an apparent increase in its 323 
molecular weight, following infection with either wt Ad5 or wt Ad12 (Figures 2A and 2B). 324 
These data suggest that SMARCAL1 is targeted for degradation during Ad infection. 325 
SMARCAL1 is degraded during Ad infection in an E1B-55K/E4orf6- and CRL- 326 
dependent manner. As E1B-55K/E4orf6 complexes and, E1B-55K, E4orf3 and E4orf6 327 
alone have all been implicated in the targeting of cellular proteins for degradation, we next 328 
investigated which early region viral proteins were required to induce SMARCAL1 329 
degradation during infection. To do this we infected A549 cells with wt Ad5, the E1B-55K 330 
deletion mutant, Ad5 dl1520, the E4orf3 deletion mutant, pm4150 and the Ad5 E4orf6 331 
deletion mutant, pm4154 and then analysed SMARCAL1 protein levels at 24h and 48h post-332 
infection (Figure 3A). In line with previous studies WB analyses revealed that p53 333 
degradation was dependent on the expression of both E1B-55K and E4orf6 (Figure 3A). 334 
Consistent with the notion that the Ad Ub ligase was also required to promote the degradation 335 
of SMARCAL1 during infection WB analyses also revealed that SMARCAL1 degradation 336 
was dependent upon the expression of both E1B-55K and E4orf6 (Figure 3A). Consistent 337 
with a role for E1B-55K in the degradation of SMARCAL1 in Ad12-infected cells, the Ad12 338 
E1B-55K deletion mutant, Ad12 dl620 was not as efficient as wt Ad12 in promoting the 339 
degradation of SMARCAL1 (Figure 3B).  340 
To investigate the role for cellular CRLs in the E1B-55K/E4orf6-dependent degradation of 341 
SMARCAL1 we utilised the NEDD8-activating enzyme (NAE) inhibitor, MLN4924, which 342 
inhibits Cullin neddylation and activation (29). As MLN4924 has been shown to be effective 343 
in the low to high nM range, and moreover, has been shown to activate p53 at high nM 344 
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concentrations (29, 30), we used two different doses to assess its efficacy as a CRL inhibitor 345 
during Ad infection. We therefore infected A549 cells with wt Ad5 or wt Ad12, then 346 
subsequently incubated infected cells in the absence, or presence, of MLN4924 and analysed 347 
SMARCAL1 protein levels at 24h and 48h post-infection (Figure 3C and 3D). WB analyses 348 
revealed that 500nM MLN4924 reduced markedly the ability of wt Ad5 and wt Ad12 to 349 
promote SMARCAL1 degradation (cf lanes 3 and 4 with lanes 11 and 12, Figures 3C and 350 
3D). As noted in other studies MLN4924 treatment, in the absence of infection promoted p53 351 
stabilisation, and consistent with other reports limited p53 degradation following Ad infection 352 
(30; cf lanes 1 and 2 with lanes 5 and 6 and 9 and 10, Figures 3C and 3D). Pertinently 353 
however, MLN4924 treatment did not affect the levels of SMARCAL1 in mock-infected 354 
cells (cf lanes 1 and 2 with lanes 5 and 6 and 9 and 10, Figures 3C and 3D). Taken together 355 
these data suggest that E1B-55K/E4orf6 recruit cellular CRLs to promote the degradation of 356 
SMARCAL1 during Ad infection. 357 
 SMARCAL1 is phosphorylated in the early stages of Ad5 and Ad12 infection. As ATR 358 
kinase is known to be activated following Ad infection and SMARCAL1 migration on SDS-359 
PAGE was retarded following infection we next investigated whether SMARCAL1 was 360 
phosphorylated in response to Ad infection. To do this we first infected A549 cells with 361 
either wt Ad5 or wt Ad12 then immunoprecipitated SMARCAL1 from mock-infected or Ad-362 
infected cells with an anti-SMARCAL1 antibody. Immunoprecipitates were then either left 363 
untreated or treated with λ-phosphatase prior to investigating the migratory properties of 364 
SMARCAL1 on SDS-PAGE. Consistent with the notion that SMARCAL1 is phosphorylated 365 
following Ad infection, WB analyses revealed that when anti-SMARCAL1 366 
immunoprecipitates from Ad-infected cells were treated with λ-phosphatase the migration of 367 
SMARCAL1 was increased, relative  to untreated samples, and comparable to the migration 368 
of SMARCAL1 from mock-infected cells (cf lanes 6 and 8 with lane 1, Figure 4A). 369 
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Treatment with the NAE inhibitor promoted limited phosphorylation of SMARCAL1 (cf 370 
lanes 3 and 4, Figure 4A).  To determine which SMARCAL1 residues were phosphorylated 371 
following Ad infection we immunoprecipitated SMARCAL1 from mock, Ad5 and Ad12 -372 
infected A549 cells and following SDS-PAGE, and gel-slice processing we subjected isolated 373 
tryptic peptides to tandem array mass spectrometry (MS/MS). MS analyses revealed that 374 
SMARCAL1 was phosphorylated at three major sites following both Ad5 and Ad12 375 
infection: S123, S129 and S173 (Figure 4B). S123 and S129 formed part of a minimal CDK 376 
consensus phosphorylation motif, SP, whilst S173 formed part of an ATR consensus 377 
phosphorylation motif, SQE. Sequence homology searches revealed that these residues were 378 
conserved amongst primates, but less well conserved for lower mammals (Figure 4C).   379 
Pharmacological inhibition of ATR kinase and CDK activities limits SMARCAL1 380 
degradation following Ad5 and Ad12 infection. Given that SMARCAL1 phosphorylation 381 
precedes its degradation following Ad infection we next investigated whether the ATR and 382 
CDK -dependent phosphorylation of SMARCAL1 during Ad infection was an essential 383 
prerequisite for the Ad-induced degradation of SMARCAL1. To do this we studied the 384 
effects of the selective ATR kinase inhibitor, AZD6738, and the CDK inhibitor, RO-3306, on 385 
the ability of both wt Ad5 and wt Ad12 to induce the degradation of SMARCAL1. Initially, 386 
therefore, A549 cells were either mock-infected or infected with wt Ad5 or wt Ad12, and then 387 
incubated in the absence or presence of AZD6738 for specific times post-infection. WB 388 
analyses revealed that treatment of A549 cells with AZD6738 reduced modestly the ability of 389 
wt Ad5 to promote the degradation of SMARCAL1 (cf lanes 7 and 8 with lanes 5 and 6, 390 
Figure 5A). Interestingly, however, the effect of AZD6738 treatment on the ability of wt 391 
Ad12 to promote SMARCAL1 degradation was much more dramatic; the ATR kinase 392 
inhibitor reduced appreciably the ability of wt Ad12 to stimulate SMARCAL1 degradation 393 
during infection, with no observable degradation at 24h post-infection (cf lanes 7 and 8 with 394 
 o
n
 April 17, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
  
17 
 
lanes 5 and 6, Figure 5B). To establish whether CDKs cooperate with ATR to promote 395 
SMARCAL1 degradation following Ad infection we infected A549 cells with either wt Ad5, 396 
or wt Ad12 then incubated infected cells in the absence, or presence, of AZD6738 and RO-397 
3306 for specific times post-infection. WB analyses revealed that the use of both inhibitors 398 
reduced substantially the ability of wt Ad5 to promote the degradation of SMARCAL1, 399 
particularly at 48h post-infection (cf lanes 5 and 6 with lanes 7 and 8, Figure 5C). Similarly, 400 
the combined effects of AZD6738 and RO-3306 were to almost abate entirely the ability of 401 
wt Ad12 to induce the degradation of SMARCAL1 (cf lanes 5 and 6 with lanes 7 and 8, 402 
Figure 5D). Taken together these data suggest strongly that the combined ATR kinase and 403 
CDK -dependent phosphorylation of SMARCAL1 facilitate the E1B-55K/E4orf6-dependent 404 
degradation of SMARCAL1 during Ad infection. As such, these studies are important in 405 
establishing that Ad can activate, and then utilise, cellular kinases during infection to promote 406 
viral replication. 407 
SMARCAL1 recruitment to VRCs is largely dependent upon its association with the 408 
RPA complex but is also regulated by ATR and CDK -dependent phosphorylation. To 409 
explore in more detail the factors that modulate the recruitment of SMARCAL1 to VRCs 410 
during Ad infection we generated a phosphorylation-defective GFP-SMARCAL1-P 411 
(S123A, S129A and S173A) mutant in order to ablate the ATR, and CDK, -dependent 412 
phosphorylation of SMARCAL1 in response to Ad infection, and utilised a GFP-413 
SMARCAL1-RPA mutant that is unable to bind the RPA complex (21). We then generated 414 
clonal, RPE-1 cell lines that expressed constitutively, either GFP alone, wt GFP-415 
SMARCAL1, GFP-SMARCAL1-P or GFP-SMARCAL1-RPA. Then, to investigate the 416 
role SMARCAL1 phosphorylation and the RPA complex play in SMARCAL1 recruitment to 417 
VRCs we infected these cell lines with either wt Ad5 or wt Ad12, and analysed GFP-418 
SMARCAL1 cellular distribution throughout the infection process. Pertinently, Ad infection 419 
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of GFP alone RPE-1 cells had no effect upon the pan-cellular distribution of GFP (data not 420 
shown). In mock-infected RPE-1 cells wt GFP-SMARCAL1, GFP-SMARCAL1-P and 421 
GFP-SMARCAL1-RPA were distributed evenly throughout the nucleus (panels i-iii, Figure 422 
6A). Following infection of RPE-1 cells with either wt Ad5, or wt Ad12, wt GFP-423 
SMARCAL1 was re-distributed to VRCs (panels iv and vii respectively, Figure 6A). 424 
Interestingly, the ability of both wt Ad5 and wt Ad12 to promote the recruitment of the GFP-425 
SMARCAL1-P mutant to VRCs, relative to wt GFP-SMARCAL1 was reduced 426 
significantly, but only by one-third (panels v and viii, Figure 6A; Figure 6B). Moreover, the 427 
ability of both wt Ad5 and wt Ad12 to promote the recruitment of GFP-SMARCAL1-RPA, 428 
relative to wt GFP-SMARCAL1, was also reduced significantly, by approximately two-thirds 429 
(panels vi and ix, Figure 6A; Figure 6B), Taken together, these data suggest that the RPA 430 
complex plays a major role in the recruitment of SMARCAL1 to VRCs during Ad infection, 431 
whilst the ATR- and CDK- dependent phosphorylation of SMARCAL1, although not 432 
essential, also contributes towards SMARCAL1 recruitment to VRCs following Ad infection. 433 
Given that ATR and CDK inhibitors restricted the ability of both wt Ad5 and wt Ad12 to 434 
promote SMARCAL1 degradation during infection, we also wished to use this experimental 435 
system to explore the specific roles of S123, S129 and S173 phosphorylation in the Ad-436 
mediated degradation of SMARCAL1. Unfortunately, Ad infection of RPE-1 cells that 437 
constitutively expressed GFP-SMARCAL1 species resulted in the enhanced expression of 438 
GFP-SMARCAL1 species, probably as a result of E1A transactivation of the CMV promoter 439 
driving the expression of GFP-SMARCAL1 species (data not shown). As such we were not 440 
able to determine the individual contribution of specific SMARCAL1 phosphorylation sites 441 
in the Ad-induced degradation process. 442 
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Ad5 and Ad12 E1B-55K associate with SMARCAL1 in Ad-transformed cells. As E1B-443 
55K has previously been shown to function as a substrate adaptor in the recruitment of 444 
cellular proteins, such as p53 and MRE11, for CRL-dependent degradation during infection 445 
we next investigated whether E1B-55K also served as an adaptor for SMARCAL1 and could 446 
be found associated with SMARCAL1 in Ad-transformed cells. To investigate whether Ad5 447 
and Ad12 E1B-55K were found associated with SMARCAL1 in Ad-transformed cells we 448 
performed reciprocal co-immunoprecipitation studies using Ad5 HEK 293 cells and Ad12 449 
HER2 cells. Consistent with the notion that E1B-55K and SMARCAL1 associate in vivo, 450 
anti-E1B-55K antibodies co-immunoprecipitated SMARCAL1, and anti-SMARCAL1 451 
antibodies co-immunoprecipitated E1B-55K, from both Ad5 HEK 293 cells and Ad12 HER2 452 
cells (Figure 7A and 7B, respectively). Given that p53 is a known E1B-55K-interacting 453 
protein, we performed reciprocal p53 and E1B-55K co-immunoprecipitation studies to 454 
validate the approach taken (Figure 7A and 7B, respectively).   455 
Generation of Ad5 and Ad12 E1B-55K FlpIn T-REX U2OS clonal cell lines. As we have 456 
shown that Ad E1B-55K can associate with SMARCAL1 in Ad-transformed cells (Figure 7) 457 
we wished to investigate the specific effects of E1B-55K expression, in isolation, upon 458 
SMARCAL1 function. To begin to do this we first generated clonal TET-inducible Ad5 and 459 
Ad12 E1B-55K FlpIn U2OS cells that upon induction with the tetracycline analogue, 460 
doxycycline, expressed Ad5 and Ad12 E1B-55K (Figure 8). Consistent with the role for Ad 461 
E1B-55K in the stabilization of the p53 tumour suppressor, p53 protein levels were also 462 
increased following both Ad5 and Ad12 E1B-55K (Figure 8). Unlike p53, the protein levels 463 
of SMARCAL1 and another E1B-55K binding partner, MRE11, were not altered appreciably, 464 
following E1B-55K expression (Figure 8). Taken together, these data demonstrate that we 465 
have generated TET-inducible Ad5 and Ad12 E1B-55K FlpIn U2OS cells that express 466 
functional E1B-55K following treatment with doxycycline. 467 
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Ad5 and Ad12 E1B-55K dysregulate DNA fork speed during cellular DNA replication 468 
and promote replication fork collapse. It is well established that in addition to its role as a 469 
substrate adaptor in the CRL-dependent degradation of p53 during Ad infection, E1B-55K 470 
can, in isolation, also inhibit the transactivation properties of p53 (31). As SMARCAL1 471 
possesses the inherent ability to prevent replication fork collapse in unperturbed S-phase and, 472 
in response to agents that promote replication stress, promote replication fork restart after 473 
fork collapse we wished to establish whether Ad E1B-55K could also modulate the cellular 474 
functions of SMARCAL1. To measure the effects of Ad E1B-55K expression upon 475 
replication fork speed during unperturbed S-phase we utilised the DNA fibre assay. To do 476 
this we pulse-labelled FlPIn U2OS cells (+/- Ad5 or Ad12 E1B-55K expression) successively 477 
with the thymidine analogues, CldU and IdU for 20 minutes each to label DNA at replication 478 
forks. DNA fibre analyses revealed that in the presence of Ad5 E1B-55K, or Ad12 E1B-55K 479 
CldU-labelled tracks of newly synthesized DNA were significantly longer, relative to mock 480 
controls, suggesting that both Ad5, and Ad12 E1B-55K expression led specifically to 481 
accelerated speeds of replication fork progression (Figures 9 A and B). Interestingly however, 482 
this accelerated fork speed at on-going DNA replication forks, in the presence of Ad E1B-483 
55K, was not maintained when cells were subsequently labelled with IdU, such that IdU track 484 
length was comparable to cells that did not express Ad E1B-55K (Figures 9 A and B). As an 485 
increased CldU/IdU ratio can be indicative of fork stalling or collapse (32) we next quantified 486 
the effects of Ad E1B-55K expression on replication fork collapse. Consistent with the notion 487 
that the Ad E1B-55K-dependent acceleration in fork speed results in replication fork 488 
collapse, cells that expressed either Ad5 or Ad12 E1B-55K had a significantly increased 489 
number of stalled replication forks (CldU-only labelled DNA fibres) relative to cells that do 490 
not express Ad E1B-55K (Figure 9C). Taken together, these data indicate that Ad E1B-55K, 491 
can in isolation, modulate cellular DNA replication, and in consideration of the known 492 
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functions of SMARCAL1, is supportive of the notion that Ad E1B-55K interaction with 493 
SMARCAL1 contributes towards dysregulated cellular DNA replication. 494 
Discussion 495 
It is now well established that Ad engages with cellular CRLs to stimulate the ubiquitin-496 
mediated degradation of a small number of cellular DDR proteins in order to promote viral 497 
replication (1, 2). Typically, E4orf6, serves to recruit CRLs to protein substrates through 498 
direct interaction with CRL components Elongin B and Elongin C, whilst E1B-55K through 499 
direct interaction with both E4orf6 and protein substrates, recruits cellular proteins to CRLs 500 
for polyubiquitylation and proteasome-mediated degradation (1, 2). Using well-established 501 
Ad5 and Ad12 mutant viruses we show that Ad likely utilizes this canonical pathway to 502 
promote the degradation of the cellular replication protein, SMARCAL1, during infection 503 
(Figures 2 and 3). Indeed, treatment with the NAE inhibitor reduced the extent of degradation 504 
of SMARCAL1 during infection, suggesting that CRLs contribute to this degradation 505 
process. 506 
It was evident during our studies that, prior to its degradation, a higher molecular weight 507 
form of SMARCAL1 was observed upon SDS-PAGE (Figure 2). In this regard we used mass 508 
spectrometry to establish that SMARCAL1 was phosphorylated on residues S123, S129 and 509 
S173 early during both Ad5 and Ad12 infection (Figure 4). S123 and S129 form part of 510 
minimal CDK consensus SP motifs and S173, forms part of a consensus ATM/ATR SQE 511 
motif. Although all of these residues have been shown previously to be phosphorylated in 512 
vivo the biological significance of these phosphorylation events has yet to be determined (28). 513 
Given that S123 and S129 are likely to be phosphorylated by a CDK and S173 is likely 514 
phosphorylated by ATR we investigated whether small molecule inhibitors of ATR kinase 515 
and CDKs could affect the ability of Ad to promote SMARCAL1 degradation. Significantly, 516 
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studies with the ATR inhibitor, AZD6738 and CDK inhibitor, RO-3306, determined that 517 
ATR and CDKs cooperate to promote the Ad-targeted degradation of SMARCAL1 during 518 
infection (Figure 5), suggesting that S123, S129 and S173 all contribute towards 519 
SMARCAL1 stability in vivo. Although RO-3306 has greater selectivity for CDK1 than 520 
CDK2 and CDK4 (33) Ad infection is known to stimulate the activity of all three kinases 521 
(34), such that we cannot, at present, state which CDK(s) is/are responsible for 522 
phosphorylating SMARCAL1 during Ad infection. We wished to investigate further the role 523 
of phosphorylation of these specific residues in the Ad-mediated degradation of 524 
SMARCAL1. To this end we made GFP-SMARCAL1 RPE-1 cell lines where S123, S129 525 
and S173 residues were all mutated to A to ablate phosphorylation at these sites. Although we 526 
were able to generate clonal cell lines that expressed these mutations, we were unable to 527 
undertake these studies as Ad infection results in the transactivation of the CMV promoter 528 
that regulates GFP-SMARCAL1 expression (data not shown).  529 
We were however, able to use the wt GFP-SMARCAL1 and GFP-SMARCAL1 phospho-530 
mutant RPE-1 cell lines to address the role of SMARCAL1 phosphorylation in the 531 
recruitment of SMARCAL1 to VRCs. As such, we determined that ATR and CDKs, although 532 
not essential, contributed to some extent in the recruitment of SMARCAL1 to VRCs during 533 
infection (Figure 6). Moreover, using a GFP-SMARCAL1 species lacking its N-terminal 534 
RPA interaction motif we were also able to establish that SMARCAL1 association with RPA 535 
is a major determinant in SMARCAL1 recruitment to VRCs (Figure 6). SMARCAL1 was 536 
initially characterized as an RPA-interacting protein, and its recruitment to replication forks 537 
and sites of DNA damage was shown to be dependent upon its interaction with RPA (21-25). 538 
More recent studies have determined that RPA in addition to its ability to control 539 
SMARCAL1 localization also confers substrate specificity and regulates SMARCAL1 fork-540 
remodelling reactions through the orientation of its high affinity DNA-binding domains (35).  541 
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RPA is a single-stranded DNA binding protein complex that has long been known to promote 542 
large T-antigen-dependent SV40 DNA replication (36). Although RPA has been shown to be 543 
recruited to Ad VRCs during infection its precise role in Ad replication is not known (19, 20). 544 
Given that SMARCAL1 is an RPA-binding protein and that most of its activities are 545 
controlled by RPA, it is interesting to speculate that any pro-viral RPA functions during Ad 546 
infection are not coordinated through the activation of SMARCAL1-dependent remodelling 547 
activities. Indeed, as SMARCAL1 is degraded during infection (Figure 2), it is highly likely 548 
that SMARCAL1 possesses anti-viral activities. As the mechanism of SV40 DNA replication 549 
is well established it would be interesting to determine the requirement for SMARCAL1 in 550 
RPA-dependent SV40 DNA replication. 551 
Given the role of SMARCAL1 in cellular DNA replication we investigated the effects of Ad 552 
E1B-55K expression on cellular DNA replication. We observed that E1B-55K expression 553 
enhanced nascent cellular DNA replication fork speed but, ultimately, E1B-55K expression 554 
resulted in increased replication fork stalling (Figure 9). It has been determined previously 555 
that loss of SMARCAL1 prevents replication re-start after replication stress, resulting in 556 
stalled replication, whilst knockdown of p53 and MRE11, also promote stalled cellular DNA 557 
replication (28, 37, 38). More generally, it has been determined that oncogene product 558 
expression can enhance replication stress to either increase, or decrease, DNA replication 559 
initiation, elongation, fork speed, fork stalling and fork re-start through the modulation of 560 
origin firing, replication-transcription collisions, reactive oxygen species, and defective 561 
nucleotide metabolism (39). It is plausible therefore that the E1B-55K oncoprotein promotes 562 
replication stress in Ad-infected cells through interaction with p53, MRE11, SMARCAL1 563 
and potentially other cellular targets that ultimately results in cellular DNA replication 564 
inhibition. Given the known role of E1B-55K in the promotion of late viral mRNA 565 
accumulation and the inhibition of cellular mRNA transport, and translation, in the mediation 566 
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of host protein shutoff, as well as the proposed role for Ad-mediated protein degradation in 567 
mRNA export (40, 41) we postulate that E1B-55K similarly inhibits cellular DNA replication 568 
and promotes viral replication through the specific targeting of cellular E1B-55K-interacting 569 
proteins for degradation during infection.  570 
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Figure Legends. 724 
FIG 1. SMARCAL1 is reorganized to viral replication centres during the early stages of Ad 725 
infection. A549 cells were either mock-infected (panels i-iii), or infected with 10 pfu/cell of 726 
wt Ad5 (panels iv-vi) or wt Ad12 (panels vii-ix).  At 18h post-infection, cells were fixed, 727 
permeabilized and co-stained for SMARCAL1 and RPA2. Arrows indicate regions of 728 
RPA2/SMARCAL1 co-localization. In all instances images were recorded using a Zeiss 729 
LSM510-Meta confocal microscope.  730 
FIG 2. SMARCAL1 is targeted for degradation during Ad infection. A549 cells were either 731 
mock-infected or infected with 10 pfu/cell of wt Ad5 or wt Ad12 and harvested at the 732 
appropriate times post-infection. (A) Ad5 cell lysates were then subject to WB for 733 
SMARCAL1, p53, E1B-55K, E4orf6 and -actin. (B) Ad12 cell lysates were subject to WB 734 
for SMARCAL1, p53, E1B-55K and -actin. h.p.i - hours post-infection. Representative of 735 
more than three independent experiments.  736 
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FIG 3. SMARCAL1 is degraded during Ad infection in an E1B-55K/E4orf6- and CRL- 737 
dependent manner. (A) A549 cells were either mock-infected, infected with wt Ad5, or 738 
infected with E1B-55K (dl1520), E4orf3 (H5pm4150) or E4orf6 (H5pm4154) deletion 739 
viruses. At 24 h and 48 h post-infection cells were harvested and subject to WB for 740 
SMARCAL1, p53, E1B-55K, E4orf3, E4orf6 and -actin. (B) A549 cells were either mock-741 
infected, infected with wt Ad12, or infected with the E1B-55K (dl620) deletion virus. At 24 h 742 
and 48 h post-infection cells were harvested and Western blotted for SMARCAL1, p53, E1B-743 
55K, and -actin. (C and D) A549 cells were either mock-infected or infected with wt Ad5 or 744 
wt Ad12, in the absence or presence of 100 nM or 500 nM MLN4924. At 24 h and 48 h post-745 
infection cells were harvested and subject to WB for SMARCAL1, p53, E1B-55K and -746 
actin. h.p.i - hours post-infection. Representative of three independent experiments. 747 
FIG 4. SMARCAL1 is phosphorylated during the early stages of Ad infection. (A) A549 748 
cells were either mock-infected, treated with MLN4924, or infected with 10 pfu/cell of wt 749 
Ad5 or wt Ad12 and harvested at 18 h post-infection. Cells were harvested in IP buffer and 750 
subject to immunoprecipitation for SMARCAL1. Anti-SMARCAL1 immunoprecipitates 751 
collected on protein G-sepharose were treated in the absence, or presence, of -phosphatase 752 
and then subject to SDS-PAGE and WB for SMARCAL1. (B) SMARCAL1 was 753 
immunoprecipitated from mock-infected and wt Ad5 or wt Ad12 infected A549 cells 18 h 754 
post-infection, and separated by SDS-PAGE. Protein bands excised from the gel were subject 755 
to trypsinization and mass spectrometric analysis. Identified SMARCAL1 phosphorylated 756 
peptides from Ad-infected cells are presented. (C)  S123, S129 and S173 are conserved 757 
between primates but less well conserved in lower mammals. SMARCAL1 primary 758 
sequences from a number of species were aligned using CLUSTAL Omega. Shaded areas 759 
indicate conserved residues.  760 
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FIG 5. ATR kinase and CDKs promote SMARCAL1 degradation following Ad5 and Ad12 761 
infection. A549 cells were either mock-infected or infected with 10 pfu/cell of wt Ad5 (A and 762 
C) or wt Ad12 (B and D). Cells were then incubated in the absence or presence of ATR 763 
inhibitor (AZD6738 (ATRi), 1 M; A and B) or ATR and CDK inhibitors (AZD6738, 1 M 764 
and RO-3306 (CDKi), 9 M; C and D) and harvested at the appropriate times post-infection. 765 
Cell lysates were then separated by SDS-PAGE and subject to WB for SMARCAL1, p53, 766 
E1B-55K, and -actin. h.p.i - hours post-infection. Representative of three independent 767 
experiments. 768 
FIG 6. SMARCAL1 is recruited to VRCs in an RPA-dependent, and ATR and CDK -769 
dependent, manner. (A) Microscopic images depicting the cellular localization of wt GFP-770 
SMARCAL1, GFP-SMARCAL1-P and GFP-SMARCAL1-RPA in mock-infected (panels 771 
i-iii), wt Ad5-infected (panels iv-vi) or wt Ad12-infected cells (panels vii-ix) 18 h post-772 
infection. (B) Bar graph (+/- S.E.M.) showing the % of GFP-labelled cells that are recruited 773 
to VRCs following Ad5 or Ad12 infection. n=3 (300 cells per experiment; 900 cells in total). 774 
Only those cells that exhibited clear GFP-SMARCAL1 structures in Ad-infected cells, 775 
comparable to the known architecture of VRCs at different stages of infection, were counted 776 
as VRC positive. Data presented was subjected to ANOVA two-tailed t-test. Significance 777 
testing for difference in recruitment of GFP-SMARCAL1-P to VRCs relative to wt GFP-778 
SMARCAL1 following Ad5 infection: p = 0.0065 (**); difference in recruitment of GFP-779 
SMARCAL1-RPA to VRCs relative to wt GFP-SMARCAL1 following Ad5 infection: p = 780 
8.8E-05 (****); difference in recruitment of GFP-SMARCAL1-P to VRCs relative to wt 781 
GFP-SMARCAL1 following Ad12 infection: p = 0.04 (*); difference in recruitment of GFP-782 
SMARCAL1-RPA to VRCs relative to wt GFP-SMARCAL1 following Ad5 infection: p = 783 
0.002 (***). 784 
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FIG 7. Ad E1B-55K associates with SMARCAL1 in Ad-transformed cells. (A) Ad E1B-55K 785 
and SMARCAL1 were immunoprecipitated from Ad5 HEK 293 cells (A) and Ad12 HER2 786 
cells (B) and subject to WB for E1B-55K and SMARCAL1. IgG, immunoglobulin control IP. 787 
FIG 8. Generation and characterization of TET-inducible Ad5 and Ad12 E1B-55K FlpIn 788 
U2OS cells. FlpIn U2OS cells were transfected with Ad5 E1B-55K and Ad12 E1B-55K 789 
pcDNA5/FRT/TO plasmids and the recombination plasmid, pOG44. Cells were incubated in 790 
selection medium containing hygromycin (200 g/ml). Individual colonies were isolated, 791 
expanded and treated with 0.1 g/ml doxycycline. 24 h post-induction cell lysates were 792 
harvested, separated by SDS-PAGE and subject to WB analysis for Ad5 and Ad12 E1B-55K. 793 
WB analyses were also performed to gauge the levels of SMARCAL1, p53, MRE11 and -794 
actin for Ad5 E1B-55K, and Ad12 E1B-55K, FlpIn U2OS cells, respectively. Representative 795 
of more than three independent experiments. 796 
FIG 9. Ad5 and Ad12 E1B-55K modulate cellular DNA replication rates and promote 797 
replication fork stalling. Uninduced, and doxycycline-induced, Ad5 and Ad12 E1B-55K 798 
FlpIn U2OS cells were labelled with 25 μM CldU and 250 μM IdU for 20 min each. DNA 799 
fibre spreads were then prepared and denatured with 2.5 M HCl. DNA fibres were labelled 800 
with the appropriate primary and secondary antibodies and visualised using a Nikon E600 801 
microscope. (A and B) Representative DNA spreads (+/- Ad5 or Ad12 E1B-55K) are shown 802 
indicating the mean fork speeds; CldU and IdU fork lengths were quantified and presented as 803 
dot plots (+/- S.D.) with the mean fork speed shown as a red bar. n = 3 (Total fibres analysed: 804 
Ad5 mock = 347; + Ad5 E1B-55K = 368; Ad12 mock = 370; + Ad12 E1B-55K = 364). (C) 805 
% stalled forks (CldU-only labelled forks) were quantified and presented as a bar chart +/- 806 
S.D. In all instances data presented was subjected to ANOVA two-tailed t-test; + Ad5 E1B-807 
55K CldU tract length relative to mock CldU tract length, p = 4.8E-20 (***); + Ad5 E1B-808 
55K CldU/IdU ratio relative to mock CldU tract length,  p= 9.44E-45 (****);  + Ad12 E1B-809 
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55K CldU tract length relative to mock CldU tract length, p = 1.29E-32 (****); + Ad12 E1B-810 
55K CldU/IdU ratio relative to mock CldU tract length, p = 6.32E-61 (****);  ns = not 811 
significant. Stalled forks: Ad5 E1B-55K relative to mock, p= 0.009 (**); Ad12 E1B-55K 812 
relative to mock, p =0.002 (**). 813 
 814 
 815 
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